AzTrials
AzTrials

Alveolar Process AtrophyNCT06190860

Platelet Rich Fibrin Treatment for the Alveolar Ridge Preservation in Smokers

A study testing Autologous Leukocyte and platelet-rich fibrin, Intraoral Scan and Computed Tomography in people with Alveolar Process Atrophy and Smoking, Cigarette, run by Universidad de los Andes, Chile at 2 sites in Chile.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Bone healing is affected by smoking, particularly healing of extraction sockets, showing deficiencies in vertical and horizontal bone dimensions compared to the healing of non-smokers. Several approaches have been made to stimulate. Bone wound healing, including human autologous blood-derived fractions. Read more about this study

Who is it for?
Ages 20 to 70 yearsHealthy volunteers can take part
What is being tested?
Autologous Leukocyte and platelet-rich fibrin, Intraoral Scan and Computed Tomography
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
16 participants
Where
2 sitesChile
Study dates
29 May 2022to 31 Mar 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Smokers (at least five cigarettes/day) have had the habit for at least one year.
  • treatment plan that includes the indication of extraction of a single, double-rooted, or multi-rooted tooth and prosthetic rehabilitation with osseointegrated implants
  • Patients with controlled systemic pathologies (hypertension, diabetes, hypercholesterolemia).
  • With alveolar bone support of at least 50% and whose indication is delayed implant placement at least four months after extraction.
  • Periapical lesions of no more than 5 mm diameter.

Who cannot join

  • patients taking immunosuppressive or anticoagulant drugs
  • pregnant
  • users of removable prostheses
  • Individuals with altered values of platelet count or coagulation parameters.

Trial locations and contacts

2 sites in 1 country.

Constanza Martínez, DDS PhD contact

56987660640

cemartinezc@uandes.cl

Chile2 sites, 2 recruiting
  • Clinical Facility, School of Dentistry, Pontificia Universidad Católica de Chile

    Santiago, Santiago Metropolitan, 7820436

    Enrolling by invitation
  • Dental facility, Health center at San Bernardo, Faculty of Dentistry, University of the Andes

    Santiago, Santiago Metropolitan, 8051285

    Guillermo Salgado, DDS, gsalgado@uandes.cl

    Recruiting

Other trials in Chile

About this study

Official title: Platelet Rich Fibrin as a Modulator of the Wound Healing Response in Smokers

Bone healing is affected by smoking, particularly healing of extraction sockets, showing deficiencies in vertical and horizontal bone dimensions compared to the healing of non-smokers. Several approaches have been made to stimulate.

Bone wound healing, including human autologous blood-derived fractions. One of these fractions is the leukocyte platelet-rich fibrin (L-PRF).

Read more

L-PRF has been evidenced as potentially beneficial in promoting bone defect filling in alveolar bone and socket preservation in non-smokers. However, scarce evidence is related to this beneficial effect in smokers.

This clinical trial aims to study and compare the in vivo effects of L-PRF during bone wound healing and regeneration in smokers.

The main question is:

Has the L-PRF a beneficial effect during alveolar ridge preservation in smokers? After consent, participants with tooth extraction indications and implant rehabilitation treatment will be enrolled. After randomization, participants will be assigned to an experimental group treated with L-PRF plugs and membranes or a control group (physiological healing).

Participants will receive two interventions:

  • First intervention: Tooth extraction, intraoral scan, and Cone Beam Computed Tomography in the treated zone.
  • Second intervention (4 months after first intervention): intraoral scan and Cone Beam Computed Tomography in the treated zone
Read the detailed description
  • This study will be conducted according to the principles outlined in the Declaration of Helsinki regarding experiments on human beings. This work was submitted and approved by the Ethics and Scientific Committee, approval number ID170706007.
  • Participant selection: Volunteers must agree to participate in the study after signing an informed consent (previously approved by the Ethics Committee). Participants will be treated at the Dental Clinical School of Dentistry at the Pontificia Universidad Católica de Chile or in the Dentistry/ Health Sciences Center at San Bernardo from the University of the Andes, Chile. Both institutions are located in Santiago, Chile.

Diagnosis and evaluation before interventions: Volunteer participants will be selected after a clinical and periapical radiographic examination to establish the need for tooth extraction. Laboratory tests, including a complete blood coagulation profile, will be required for all volunteers. Finally, a salivary cotinine test will ensure the smoker's condition.

  • Randomization: A random number will be assigned to all participants. An independent research team member will establish a randomization sequence without contact with the clinician's team. Sealed envelopes with randomization will be performed and opened by surgeons before the tooth extraction.
  • First Intervention: Participants assigned to the experimental group will be treated with L-PRF plugs and membranes from venous blood. Participants will have drawn blood after venipuncture (median cubital vein) into sterile, glass-coated plastic 9 mL tubes without anticoagulant. These tubes will be centrifuged at 2700 rpm for 12 min (Relative Centrifugal Forces-clot = 408 g). After tooth extraction, participants in the experimental group will be treated with L-PRF plugs and membranes, and the control group will be sutured. Participants in both groups will be intraoral scan and intraoral scan and Cone Beam Computed Tomography in the treated zone. Clinicians will make a post-surgical control to evaluate how healing will be performed.
  • Second Intervention: Four months after the first Intervention, participants will recall getting a second scan and Cone Beam Computed Tomography in the treated zone. Images will be used for implant treatment planification. Before implant placement, a biopsy (2 mm in diameter) will be taken. The biopsy will be analyzed by Micro-computed tomography and decalcified and included in paraffin for histological sections.
  • The primary outcome variable established will be radiographic linear changes in horizontal width and vertical height of the alveolar ridge measured in the CBCTs taken immediately after tooth extraction and after four months. Secondary outcomes included the changes in ridge contours and volume estimated from the intraoral scan images.
  • Data analysis: Members of the research team who do not know the group intervention of the participants will determine alveolar ridge height and width in oral scans and CBCTs taken in the first and second Interventions. As such, micro-CT analysis and histological sections will be analyzed.
  • Statistical analysis The results will express the mean ± 95% CI. Will be considered as significant differences when P < 0.05. Nominal data will be evaluated.
Being tested
Autologous Leukocyte and platelet-rich fibrin, Intraoral Scan, Computed Tomography, Biopsy
Medical subject headings
Alveolar Bone Loss, Cigarette Smoking

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Autologous Leukocyte and platelet-rich fibrinOther

    Participants will be treated with L-PRF plugs and membranes from autologous venous blood. Participants will have drawn blood after venipuncture (median cubital vein) into sterile, glass-coated plastic 9 mL tubes without anticoagulant. These tubes will be centrifuged at 2700 rpm for 12 min (Relative Centrifugal Forces-clot = 408 g). After tooth extraction, participants in the experimental group will be treated with L-PRF plugs and membranes.

  • Intraoral ScanOther

    Intraoral scan will be taken in the treated zone after tooth extraction and after four months.

  • Computed TomographyRadiation

    Cone Beam Computed Tomography in the treated zone will be taken after tooth extraction and after four months.

  • BiopsyOther

    Before dental implant placement, a biopsy (2 mm in diameter) will be taken. The biopsy will be analyzed by Micro-computed tomography and decalcified and included in paraffin for histological sections.

Study groups in NCT06190860
Study groupRoleWhat they receive
ControlOtherPost-extraction sockets will be sutured and left to heal spontaneously with physiological blood clot. First intervention: intraoral scan and intraoral scan and Cone Beam Computed Tomography in the treated zone. Clinicians will make a post-surgical control to evaluate how healing will be performed Four months after the first Intervention, participants will recall getting a second scan and Cone Beam Computed Tomography in the treated zone. Images will be used for implant treatment planification. Before implant placement, a biopsy (2 mm in diameter) will be taken. The biopsy will be analyzed by Micro-computed tomography and decalcified and included in paraffin for histological sections.
Receives: Other: Intraoral Scan; Radiation: Computed Tomography; Other: Biopsy
L-PRF TreatmentExperimentalPost-extraction sockets will be treated with L-PRF plugs and membranes. First intervention: intraoral scan and intraoral scan and Cone Beam Computed Tomography in the treated zone. Clinicians will make a post-surgical control to evaluate how healing will be performed Four months after the first Intervention, participants will recall getting a second scan and Cone Beam Computed Tomography in the treated zone. Images will be used for implant treatment planification. Before implant placement, a biopsy (2 mm in diameter) will be taken. The biopsy will be analyzed by Micro-computed tomography and decalcified and included in paraffin for histological sections.
Receives: Other: Autologous Leukocyte and platelet-rich fibrin; Other: Intraoral Scan; Radiation: Computed Tomography; Other: Biopsy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Alveolar ridge changes

    linear changes in horizontal width and vertical height of the alveolar ridge measured in the CBCTs taken immediately after tooth extraction and after four months.

    Measured: inmediately after tooth extraction and after four months

Secondary outcomes (2)
  1. Alveolar ridge sof tissue changes

    changes in ridge contours and volume estimated from the intraoral scan images

    Measured: inmediately after tooth extraction and after four months

  2. Tissue healing

    Tissue analysis by Micro-CT and histological sections.

    Measured: Biopsy at least four months after tooth extraction

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Jan 2024
  2. Study start29 May 2022
  3. Primary completion31 Dec 2023 (estimated)
  4. Study completion31 Mar 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
16 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06190860
Sponsor's protocol ID
1181007
Status last verified
Dec 2023
First submitted
19 Dec 2023
Last updated
5 Jan 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Individual participant data will underlie results in a publication.

Questions about this trial

What is this clinical trial studying?

A study testing Autologous Leukocyte and platelet-rich fibrin, Intraoral Scan and Computed Tomography in people with Alveolar Process Atrophy and Smoking, Cigarette, run by Universidad de los Andes, Chile at 2 sites in Chile.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 5 Jan 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Chile. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Constanza Martínez, DDS PhD (56987660640, cemartinezc@uandes.cl), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Alveolar ridge changes (time frame: inmediately after tooth extraction and after four months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Jan 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in